| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.013 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |